Slate Bio pulls in $1.75m

Slate Bio Inc, a pre-clinical stage biotechnology company that spun out of the University of Virginia, has raised $1.75 million in financing.

Slate Bio Inc, a pre-clinical stage biotechnology company that spun out of the University of Virginia, has raised $1.75 million in financing. Epidarex Capital led the round.

Source: Press Release